Report Title: Biomedical Polymer Materials and Applications
Report Time: 9:00am, January 6,2025
Report Site: Lecture Hall, 2nd Floor, Conference Center, Jiangning Campus, China Pharmaceutical University
Chen Xuesi, born in December 1959, is an academician of the Chinese Academy of Sciences, a researcher of Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, and the executive deputy director of the Institute's Academic Committee. 2016, he was elected as a Fellow of the International Union of Biomaterials and Engineering, and in 2022, he was elected as a Fellow of the American Academy of Medicine and Bioengineering. He serves as the editor-in-chief of Polymer Science&Technology journal, deputy editor-in-chief of Science China-Materials journal, and presides over the 14th Five-Year Plan of the Ministry of Science and Technology of the People's Republic of China (MOST) and the National Foundation of China (NFC) Center for Basic Science. He has been engaged in polymer chemistry and physics research for a long time. He has developed two major types of degradable materials, namely, high purity PLA and polyamino acid, and realized the industrialization of PLA plastics and medical polymer materials and devices, and has obtained 14 pieces of Chinese medical device registration certificates of Kawasaki class. We cooperated with Zhejiang Haizheng Biomaterials Co., Ltd. to realize the industrialization of 60,000 tons of PLA, and the company has been successfully listed. Ltd. to establish the second full chain production line of 75,000 tons of lactic acid and 50,000 tons of polylactic acid, set up academician scientific research park in Lianhuashan District of Changchun City, and established Changchun Sainomax Bio-medical Materials and Sainomax Amazing Technology Co. He has published more than 1,000 papers with more than 50,000 citations and 122 h-factor, and has been authorized more than 300 Chinese invention patents.
